Literature DB >> 2942110

Characterization of calf liver glucosidase I and its inhibition by basic sugar analogs.

J Schweden, C Borgmann, G Legler, E Bause.   

Abstract

Glucosidase I, the enzyme catalyzing the first step of N-linked oligosaccharide processing, has been purified from calf liver crude membranes [H. Hettkamp, G. Legler, and E. Bause, (1984) Eur. J. Biochem. 142, 85-90]. Binding experiments with concanavalin A-Sepharose suggest that glucosidase I is a glycoprotein with high-mannose carbohydrate chain(s). The enzyme has a subunit molecular mass of approximately 83 kDa and specifically hydrolyzes the terminal alpha-1,2-linked glucose residue from the natural Glc3-Man9-GlcNAc2 oligosaccharide. Studies with a variety of substrates modified in the aglycon moiety suggest that the Glc2 branch rather than the more distant domains of the substrate molecule are important for binding and hydrolysis. Glucosidase I does not require metal ions for activity and is strongly inhibited by 1-deoxynojirimycin (dNM) and its N-alkyl derivatives. Ki values range from 0.07 microM for N-methyl-dNM to 1.0 microM for dNM, measured at the pH-optimum of enzyme activity. The pH dependence of inhibition indicates that the cationic form of the inhibitors is the active species. Comparison of the Ki for N-decanoyl-dNM (approximately 70 microM) with that of N-decyl-dNM (approximately 0.4 microM) suggests that electrostatic interactions at the catalytic site of the enzyme are important for inhibitor binding. 1-Deoxymannojirimycin, previously assumed to be a specific mannosidase inhibitor, as well as its N-methyl and N-5-carboxypentyl derivatives, inhibit glucosidase I with Ki values around 190, 17, and 100 microM, respectively. This apparent lack of specificity shows that in vivo experiments on N-glycoprotein processing as well as the interpretation of results with these mannosidase inhibitors may give misleading results when these compounds are used in the millimolar range.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942110     DOI: 10.1016/0003-9861(86)90429-7

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

1.  Specificity of Processing α-glucosidase I is guided by the substrate conformation: crystallographic and in silico studies.

Authors:  Megan K Barker; David R Rose
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

2.  Asparagine-linked oligosaccharides of BHK cells treated with inhibitors of oligosaccharide processing.

Authors:  R C Hughes; L Foddy; E Bause
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

3.  A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency.

Authors:  G J Gerwig; E Bause; L K Nuytinck; J F Vliegenthart; W Breuer; J P Kamerling; M F Espeel; J J Martin; N W Chan; G A Dacremont
Journal:  Am J Hum Genet       Date:  2000-04-28       Impact factor: 11.025

4.  Heterologous expression and characterization of processing α-glucosidase I from Aspergillus brasiliensis ATCC 9642.

Authors:  Takatsugu Miyazaki; Yuji Matsumoto; Kana Matsuda; Yuma Kurakata; Ichiro Matsuo; Yukishige Ito; Atsushi Nishikawa; Takashi Tonozuka
Journal:  Glycoconj J       Date:  2011-10-22       Impact factor: 2.916

Review 5.  Quality control of glycoprotein folding and ERAD: the role of N-glycan handling, EDEM1 and OS-9.

Authors:  Jürgen Roth; Christian Zuber
Journal:  Histochem Cell Biol       Date:  2016-11-01       Impact factor: 4.304

6.  Characterization of trimming Man9-mannosidase from pig liver. Purification of a catalytically active fragment and evidence for the transmembrane nature of the intact 65 kDa enzyme.

Authors:  J Schweden; E Bause
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

7.  Aminosugar derivatives as potential anti-human immunodeficiency virus agents.

Authors:  A Karpas; G W Fleet; R A Dwek; S Petursson; S K Namgoong; N G Ramsden; G S Jacob; T W Rademacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Distribution and elimination of the glycosidase inhibitors 1-deoxymannojirimycin and N-methyl-1-deoxynojirimycin in the rat in vivo.

Authors:  E D Faber; R Oosting; J J Neefjes; H L Ploegh; D K Meijer
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

9.  Disposition of glycosidase inhibitors in the isolated perfused rat liver: hepatobiliary and subcellular concentration gradients of 1-deoxymannojirimycin and N-methyl-1-deoxynojirimycin.

Authors:  E D Faber; J H Proost; R Oosting; D K Meijer
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

10.  Glucosidase II and N-glycan mannose content regulate the half-lives of monoglucosylated species in vivo.

Authors:  Ivan D Stigliano; Solana G Alculumbre; Carlos A Labriola; Armando J Parodi; Cecilia D'Alessio
Journal:  Mol Biol Cell       Date:  2011-04-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.